Search research articles
Contact Us
Filters
Showing results (161-170 of 254) with videos related to
Page
of 26
Sort By:
Pediatric Research
|
December 2, 2023
Myeloid-derived suppressor cells and T cell populations in children with Multisystem Inflammatory Syndrome
Katherine E Bline, Anna L Wilt, Robin N Alexander, et al.
The Journal of Infectious Diseases
|
October 14, 2017
Prefusion F, Postfusion F, G Antibodies, and Disease Severity in Infants and Young Children With Acute Respiratory Syncytial Virus Infection
Cristina Capella, Supranee Chaiwatpongsakorn, Erin Gorrell, et al.
The Pediatric Infectious Disease Journal
|
September 24, 2015
Axillary, Oral and Rectal Routes of Temperature Measurement During Treatment of Acute Kawasaki Disease
John T Kanegaye, Jefferson M Jones, Jane C Burns, et al.
Scientific Reports
|
June 4, 2020
Baseline and Disease-Induced Transcriptional Profiles in Children with Sickle Cell Disease
Susan Creary, Chandra L Shrestha, Kavitha Kotha, et al.
Scientific Reports
|
August 9, 2020
Author Correction: Baseline and Disease-Induced Transcriptional Profiles in Children with Sickle Cell Disease
Susan Creary, Chandra L Shrestha, Kavitha Kotha, et al.
Msphere
|
May 14, 2025
Altered nasal and oral microbiomes define pediatric sickle cell disease
Audra L Crouch, Beatrice M Severance, Susan Creary, et al.
The Journal of Infectious Diseases
|
October 6, 2022
Type III Interferons, Viral Loads, Age, and Disease Severity in Young Children With Respiratory Syncytial Virus Infection
Jeanette Taveras, Cristina Garcia-Maurino, Melissa Moore-Clingenpeel, et al.
The Pediatric Infectious Disease Journal
|
September 6, 2023
Clinical Relevance of RSV and SARS-CoV-2 Coinfections in Infants and Young Children
Rosa Rodriguez-Fernandez, Felipe González-Martínez, Jimena Perez-Moreno, et al.
Lancet (London, England)
|
February 28, 2014
Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial
Adriana H Tremoulet, Sonia Jain, Preeti Jaggi, et al.
Frontiers in Pediatrics
|
June 23, 2022
Myeloid-Derived Suppressor Cells and Clinical Outcomes in Children With COVID-19
Katherine Bline, Angel Andrews, Melissa Moore-Clingenpeel, et al.
Page
of 26
Search research articles
Search
Showing results (161-170 of 254) with videos related to
Sort By:
Page
of 26
Pediatric Research
|
December 2, 2023
Myeloid-derived suppressor cells and T cell populations in children with Multisystem Inflammatory Syndrome
Katherine E Bline, Anna L Wilt, Robin N Alexander, et al.
The Journal of Infectious Diseases
|
October 14, 2017
Prefusion F, Postfusion F, G Antibodies, and Disease Severity in Infants and Young Children With Acute Respiratory Syncytial Virus Infection
Cristina Capella, Supranee Chaiwatpongsakorn, Erin Gorrell, et al.
The Pediatric Infectious Disease Journal
|
September 24, 2015
Axillary, Oral and Rectal Routes of Temperature Measurement During Treatment of Acute Kawasaki Disease
John T Kanegaye, Jefferson M Jones, Jane C Burns, et al.
Scientific Reports
|
June 4, 2020
Baseline and Disease-Induced Transcriptional Profiles in Children with Sickle Cell Disease
Susan Creary, Chandra L Shrestha, Kavitha Kotha, et al.
Scientific Reports
|
August 9, 2020
Author Correction: Baseline and Disease-Induced Transcriptional Profiles in Children with Sickle Cell Disease
Susan Creary, Chandra L Shrestha, Kavitha Kotha, et al.
Msphere
|
May 14, 2025
Altered nasal and oral microbiomes define pediatric sickle cell disease
Audra L Crouch, Beatrice M Severance, Susan Creary, et al.
The Journal of Infectious Diseases
|
October 6, 2022
Type III Interferons, Viral Loads, Age, and Disease Severity in Young Children With Respiratory Syncytial Virus Infection
Jeanette Taveras, Cristina Garcia-Maurino, Melissa Moore-Clingenpeel, et al.
The Pediatric Infectious Disease Journal
|
September 6, 2023
Clinical Relevance of RSV and SARS-CoV-2 Coinfections in Infants and Young Children
Rosa Rodriguez-Fernandez, Felipe González-Martínez, Jimena Perez-Moreno, et al.
Lancet (London, England)
|
February 28, 2014
Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial
Adriana H Tremoulet, Sonia Jain, Preeti Jaggi, et al.
Frontiers in Pediatrics
|
June 23, 2022
Myeloid-Derived Suppressor Cells and Clinical Outcomes in Children With COVID-19
Katherine Bline, Angel Andrews, Melissa Moore-Clingenpeel, et al.
Page
of 26